Restoration of bone structure using allogeneic HAP in animals with experimental osteoreorption.

INJECTION METHOD FOR INJECTION OF HYDROXYAPATITIS.
Ectopic implantation in the femoral muscle (40 mg).

Depot "allogeneic hydroxyapatite" in the muscle. first day of introduction.

Scanning electron microscopy. Magnification: 30.
TECHNOLOGY FOR PRODUCING ALLOGENOUS HYDROXYAPATITIS.

ALLOGENIC HYDROXYAPATITIS (HAP)
CHEMICAL COMPOSITION

• Inorganic component
Ca - 413-537 mg / g
P -167-380 mg / g
Mg -1.30-3.50 mg / g
Fe - 0.09-0.026 mg / g
Zn - 0.01-0.820 mg / g
Co - 0,011-0,024 mg / g
Cr - 0.006-0.020 mg / g
Ag - 0.009-0.02 mg / g
• Organic component
Chondroitin sulfate - 0.08-0.140 mg / g
Collagen - 336.5 mg / g
ELECTRONIC MICROSCOPY OF ALLOGENIC HYDROXYAPATITIS
Scanning probe microscopy

3D image of a porous surface with GAP particles
Transmission microscopy

Nanoparticle "allogeneic hydroxyapatite". TEM × 165120
PURPOSE OF THE STUDY
At the preclinical stage, using morphological methods, determine the degree of effectiveness and safety of the injection method of using allogenic HAP for the prevention and treatment of osteoporosis.
PRECLINICAL TESTS
IN VITRO CELL CULTURES

RESEARCH METHODS
- Electron microscopy
IN VIVO ANIMALS

Hydroxyapatitis
The crystals of the mineral component of bone tissue - "Allogenic hydroxyapatite" series "Lyoplast" ® pH> 8
Pronounced proliferation, restoration of monolayer density. Stimulation of collagenogenesis.

Dermal fibroblasts 1 day. Inverted microscope. Magnification: 100

Dermal fibroblasts 4 days. Inverted microscope. Magnification: 100
DEPOT OF ALLOGENIC HAP IN MUSCLE TISSUE
RASTER ELECTRONIC MICROSCOPY

1 day after administration

10 days after administration
MUSCLE TISSUE IN THE ALLOGENOUS HAP INJECTION AREA
MUSCLE TISSUE IN THE INJECTION AREA WITHOUT CHANGES

Coloring by van gieson. Magnification: 100
DISSEMINATION OF ALLOGENIC HAP

Coloring by Van Koss. Magnification: 100
HYPESTROGENIC MODEL OF OSTEOPOROSIS
BILATERAL OVARIOECTOMY 2.5 MONTHS

Color: Van Gieson. Magnification: 100
1 - destruction of bone beams;
2 - thinning of bone beams;
3 - resorption niche with an osteoclast.

Color: hematoxylin and eosin. Magnification: 400
PREVENTION OF OSTEORESORPTION
the introduction of allogenic HAP on the day of surgery

Color: hematoxylin and eosin. Increase: 100
Bone tissue remodeling
HAP INTRODUCTION IN 1 MONTH AFTER OVARIOEKTOMY
2.5 months from the start of the experiment

1 - active osteoblasts;
2 - newly formed bone tissue.
Coloring: Hematoxylin and eosin. Magnification: 400
NO PATHOLOGICAL CHANGES
OF THE INTERNAL RAT ORGANS AT THE INTRODUCTION OF ALLOGENIC HAP
Drug kidney. Coloring: CHIC reaction according to Mac Manus. Magnification: 400
Spleen preparation. Color: hematoxylin and eosin. Magnification: 40

ABSENCE OF PATHOLOGICAL CHANGES AND CALCIFICATES
AT THE INTRODUCTION OF ALLOGENIC HAP
Lung tissue preparation. Color: hematoxylin and eosin. Magnification: 400

Lung tissue preparation. Color: Van Cossu. Magnification: 400

Clinical and experimental research. The effectiveness of the treatment of patients with secondary edentulous in the early stages after the extraction of teeth using new designs of dental implants.
Read more
Clinical and experimental research. Evaluation of the effectiveness of the use of demineralized spongiosa "Lyoplast-S" ® in the treatment of alveolitis and tooth-containing cysts in children and adults.
Read more
Clinical, experimental and laboratory research. Improving the efficiency and quality of dental care for patients with various forms of partial and complete edentulous.
Read more
Overview of the properties and criteria for the selection of materials in different clinical situations: autografts, alloimplants, xenoimplants, hydroxyapatite, synthetics, glass ceramics, composites, etc.
Read more